Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming-growth-factor-β-mediated Smad3 activation in fibroblasts
Tracy L. McGaha, Robert G. Phelps, Harry Spiera, Constantin Bona
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming-growth-factor-β-mediated Smad3 activation in fibroblasts'. Together they form a unique fingerprint.